Herrington, W. G., Staplin, N., Wanner, C., Green, J. B., Hauske, S. J., Emberson, J. R., . . . Haynes, R. (2023). Empagliflozin in Patients with Chronic Kidney Disease. The New England journal of medicine, 388(2), 117-127. https://doi.org/10.1056/NEJMoa2204233
Citácia podle Chicago (17th ed.)Herrington, William G., et al. "Empagliflozin in Patients with Chronic Kidney Disease." The New England Journal of Medicine 388, no. 2 (2023): 117-127. https://doi.org/10.1056/NEJMoa2204233.
Citácia podľa MLA (8th ed.)Herrington, William G., et al. "Empagliflozin in Patients with Chronic Kidney Disease." The New England Journal of Medicine, vol. 388, no. 2, 2023, pp. 117-127, https://doi.org/10.1056/NEJMoa2204233.
Upozornenie: Tieto citáce sú generované automaticky. Nemusia byť úplne správne podľa citačných pravidiel..